Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Publish Date: 2026-03-23 07:35:00
Source Domain: www.manilatimes.net
- New Leadership in AI: Royalty Pharma plc appointed Lucas Glass as Head of Artificial Intelligence, effective April 2026.
- Experience and Expertise: Lucas brings over a decade of experience in AI and data solutions relevant to life sciences.
- Vision for AI Integration: The company plans to enhance decision-making and operational efficiency through AI-driven automation and analytics.
- Leadership Statement: CEO Pablo Legorreta emphasized the move as a strategic step toward incorporating cutting-edge technology to improve the company’s operations.
- Important Career Background: Lucas previously served as Senior Vice President of Technology at IQVIA and held significant roles at Routine Recovery and the U.S. Department of Justice.
- Educational Background: Lucas completed a BA in Physics, an MS in Biostatistics, and doctoral studies in Statistics.
- About Royalty Pharma: The company is a prominent player in the biopharmaceutical royalties market, investing in a wide array of biopharmaceutical therapies and development-stage products.
- Forward-Looking Statements: The announcement includes a note on forward-looking statements and cautions on risks associated with such projections.
